Developing a Prediction Model for Benefit From Fulvestrant in Heavily Pretreated Metastatic Breast Cancer Patients
Breast Cancer Research - United Kingdom
doi 10.1186/bcr2312
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2009
Authors
Publisher
Springer Science and Business Media LLC